Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Thermo Fisher Scientific Inc (TMO)

3K + Investors. Track Smart Money conviction in TMO. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +28
Streak
1Q ▲
Buyers last Q
46%

Smart Money Signals — TMO

Based on 2620 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 1 quarter in a row

last 6Q
For 1 consecutive quarter, more hedge funds added TMO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (98% of max)

98% of all-time peak
2,620 hedge funds hold TMO right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +9% more funds vs a year ago

fund count last 6Q
+207 new funds entered over the past year (+9% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟠

More sellers than buyers — 46% buying

1168 buying1355 selling
Last quarter: 1,355 funds reduced or exited vs 1,168 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.
📈

More new buyers each quarter (+38 vs last Q)

new funds entering per quarter
Funds opening a new TMO position: 256 → 377 → 186 → 224. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

73% of holders stayed for 2+ years

■ 73% conviction (2yr+) ■ 14% medium ■ 13% new
1,908 out of 2,620 hedge funds have held TMO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💎

Buying through price weakness — shares +90%, value +4%

Value
+3%
Shares
+90%
Last quarter: funds added +90% more shares while total portfolio value only changed +4%. Institutions were buying while the price was falling — a high-conviction accumulation signal. They're deliberately loading up on the dip.
📊

Peak discovery — momentum slowing

199 → 256 → 377 → 186 → 224 new funds/Q
New funds entering each quarter: 256 → 377 → 186 → 224. TMO is well-known in the hedge fund world, but fresh entries are gradually declining. The explosive phase of institutional discovery is likely behind us.
🏛️

Veteran-anchored — 74% veterans vs 16% newcomers

■ 74% veterans ■ 10% 1-2yr ■ 16% new
Entry-cohort mix of 2,692 holders: 2,002 (74%) are 2+ year veterans, 270 entered 1–2 years ago, and 420 (16%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
🏆

Elite ownership — 60% AUM from top-100 funds

60% from top-100 AUM funds
75 of 2613 holders are among the 100 largest funds by AUM, controlling 60% of total institutional value in TMO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.
3.5
out of 10
Low Exit Risk
Exit risk score 3.5/10 — low institutional crowding. Ownership is below peak levels, holder base is relatively sticky, and buying momentum is positive.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — TMO

In 2026 Q2, 1168 hedge funds were net buyers of TMO (224 opened a new position, 944 added to an existing one), while 1355 reduced or exited (1159 trimmed, 196 sold completely) — a 46% buyer ratio, indicating roughly balanced activity. 60% of total institutional value in TMO is held by top-100 AUM funds, reflecting elite-tier ownership quality. Net fund flow last quarter: +28 funds (more new holders than closures). Total institutional holders: 2620.

Hedge Fund Ownership: TMO

How many hedge funds hold TMO — quarterly history vs. share price
Quarterly hedge fund ownership of TMO vs. share price

Market Analysis: TMO

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: TMO

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Is It Too Late to Buy Thermo Fisher Scientific Inc (TMO) Based on Hedge Fund 13F Filings?

Signal Freshness measures how much TMO has moved relative to its sector benchmark (XLV) since the 2026 Q2 13F filing. A stock that has barely outrun its sector is still a relatively fresh entry point — the fund's thesis has not yet been priced in by the broader market.

Since Quarter End June 30, 2026 · 81d ago
TMO
+31.3%
XLV
+6.1%

TMO outperformed XLV by +25.2% since June 30, 2026.

Since 13F Filing Date August 14, 2026 · 36d ago
TMO
+12.0%
XLV
+0.6%

Since the filing became public, TMO outperformed XLV by +11.4% .

Interpretation: The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference. Learn more →

Smart Money Signal ?
Broad Consensus, Selective Conviction

Many quality funds hold this stock, but top-tier positions remain relatively small.

76 top-rated funds 56 high-conviction
Consensus
8.2
/ 10
breadth
×
Elite
5.3
/ 10
conviction
Hedge Fund Positioning: TMO
3K + Investors

Track Smart Money conviction in TMO. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 2592 2592 -
13F Shares 352M 334M 5.41%
Total Value $163.64B $158.59B 3.19%
New Positions 216 186 +30
Increased Positions 918 965 -47
Closed Positions 209 277 -68
Reduced Positions 1135 1081 +54
Total Calls 39 35 11.43%
Total Puts 39 37 5.41%
PUT/CALL Ratio 1.0 1.06 Neutral

Statistics: TMO

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

3K + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in TMO. Verified SEC 13F-HR filings.

QUARTER:
Top 25 TMO holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Teca Partners, LP 19.16% 44,455 $22.3M
2 Cryder Capital Partners LLP 13.24% 419,181 $210.2M
3 Spinecap SAS 10.86% 72,481 $36.3M
4 Lindsell Train Ltd 9.81% 514,512 $258.0M
5 Unisphere Establishment 8.79% 2,060,000 $1.03B
6 EdgePoint Investment Group Inc. 8.26% 2,179,650 $1.09B
7 Veritas Asset Management LLP 7.96% 882,873 $442.6M
8 R.H. Dinel Investment Counsel, Inc. 6.90% 17,921 $9.0M
9 Caledonia Investments plc 6.34% 111,767 $56.0M
10 Wormser Freres Gestion 6.32% 21,764 $11.2M
11 Freshford Capital Management, LLC 6.21% 36,192 $18.1M
12 Glenview Capital Management, LLC 5.73% 627,240 $314.5M
13 Southpoint Capital Advisors LP 5.70% 500,000 $250.7M
14 Route One Investment Company, L.P. 5.65% 280,400 $140.6M
15 Navera Investment Management Ltd. 5.34% 397,439 $199.1M
16 Wilson Asset Management (international) Pty Ltd 5.24% 38,032 $19.1M
17 DKRT Investments Corp. 5.15% 42,000 $21.1M
18 CDAM (UK) Ltd 5.04% 38,960 $19.5M
19 America First Investment Advisors, LLC 4.94% 53,146 $26.6M
20 Redwood Grove Capital, LLC 4.93% 38,800 $19.5M
21 Ravenstone Capital Management Inc. 4.85% 23,658 $11.9M
22 Rempart Asset Management Inc. 4.83% 46,972 $23.5M
23 Davis-Rea LTD. 4.80% 33,558 $16.8M
24 Nexus Investment Management ULC 4.33% 66,292 $33.2M
25 C Partners Holding GmbH 4.33% 28,477 $14.3M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Thermo Fisher Scientific Inc (TMO)

What does the Smart Money Trend signal show for TMO?

Buying streak — 1 quarter in a row: For 1 consecutive quarter, more hedge funds added TMO than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for TMO?

More sellers than buyers — 46% buying: Last quarter: 1,355 funds reduced or exited vs 1,168 that bought or added. When more than half of active funds are selling, it's a caution flag — especially if the stock price hasn't moved down yet.

What is the fund quality score for TMO holders?

Elite ownership — 60% AUM from top-100 funds: 75 of 2613 holders are among the 100 largest funds by AUM, controlling 60% of total institutional value in TMO. When the biggest players dominate the cap table, it signifies deep institutional support — since mega-funds deploy the most rigorous due diligence and capital.

How long have hedge funds held TMO?

73% of holders stayed for 2+ years: 1,908 out of 2,620 hedge funds have held TMO for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Is it too late to buy Thermo Fisher Scientific Inc (TMO) following the 2026 Q2 hedge fund 13F filings?

As of today, TMO has moved +12.0% since the 2026 Q2 13F filing date (August 14, 2026), compared to +0.6% for the XLV sector ETF — an outperformance of +11.4%. Since the quarter end (June 30, 2026), TMO has gained +31.3% vs +6.1% for XLV. The stock has meaningfully outrun its sector. The trade has partially played out; entry is at a premium to the fund's implied reference.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →